triazolam 0.125 mg

1 INDICATIONS AND USAGE Triazolam tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Triazolam tablets are a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.

zydus pharmaceuticals usa inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] fatigue` `[4] nausea` `[5] pain` `[6] diarrhoea` `[7] headache` `[8] vomiting` `[9] dyspnoea` `[10] fall`

2 years ago

OVAL WHITE 1521

16 HOW SUPPLIED/STORAGE AND HANDLING

TRIAZOLAM Tablets USP, 0.125 mg are white to off-white, elliptical tablet, plain on one side and debossed with "1521" on other side of tablet and are supplied as follows: NDC 70710-1521-8 in bottles of 10 tablets with child-resistant closure NDC 70710-1521-1 in bottles of 100 tablets with child-resistant closure NDC 70710-1521-5 in bottles of 500 tablets

TRIAZOLAM Tablets USP, 0.25 mg are light-grayish blue, elliptical, mottled, scored tablet, plain on one side and debossed with "12" and "89" on either side of scoreline and are supplied as follows: NDC 70710-1289-8 in bottles of 10 tablets with child-resistant closure NDC 70710-1289-1 in bottles of 100 tablets with child-resistant closure NDC 70710-1289-5 in bottles of 500 tablets Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP.

More pills like OVAL 1521

Related Pills

triazolam 0.25 mg

zydus pharmaceuticals usa inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site